Skip to Main Content
Article navigation
Significance

The deal, which values Areva NP at 2.7 billion euros (3 billion dollars), is in effect a bailout designed to secure the survival of Areva and the French nuclear supply chain.

Impacts

The deal must undergo due diligence, expected to take until the fourth quarter of 2015. It also faces regulatory scrutiny.

The parties aim to close the deal in the second half of 2016.

Areva's likely public recapitalisation is expected to be announced in September this year.

Areva's financing woes leave the international field clearer for Russia's Rosatom, among others.

You do not currently have access to this content.
Don't already have an account? Register

Purchased this content as a guest? Enter your email address to restore access.

Please enter valid email address.
Email address must be 94 characters or fewer.

or Create an Account

Close Modal
Close Modal